This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. PROJECT #2: STEM CELLS AND DIABETIC CARDIOMYOPATHY The central hypothesis of this project is that diabetes produces negative effects on the growth reserve of cardiac stem cells (CSC) so that the enhanced cell's death cannot be counteracted by repopulating cells that preserve the architecture and function of the myocardium. To test this hypothesis, the murine models of type 1 and 2 diabetes (T1D, T2D) will be used in the following specific aims (SA): 1. SA1 is to examine whether CSC from normal mice will exhibit differences of stemness and pluripotency compared with CSC from diabetic mice. The whole heart of T1D and T2D mice will be used to isolate and identify CSC with c-kit positive, sca1 positive, MDR1 positive, also Lineage negative antigens and/or frozen tissue sections from those tissues will be stained for the markers. The total number of CSC, distribution in cardiac tissue, stem cell proliferation, and in vitro cardiac lineage differentiation will be compared between diabetic and non-diabetic groups. Flow cytometry, immunocytochemistry, immunohistochemistry, and echocardiography techniques will be used in these experiments. 2. SA2 is to investigate how diabetes and hyperglycemia impairs the stemness and cardiac lineage differentiation of CSC isolated from diabetic and non-diabetic hearts. Gene and protein expression patterns in c-kit, sca1, MDR1, AMPK, P53, PI3K/Akt, Nxk2.5, Glut1&4 of CSC from diabetic hearts will be compared with those from non-diabetic CSC. Cardiac lineage markers will be checked before and after in vitro differentiation. To mimic the in vivo diabetic condition, normal CSC of control hearts will also undergo in vitro hyperglycemia treatments. The underlying mechanism related with the genes and protein change under in vivo and in vitro conditions will be explored accordingly. Gene chip, protein array, Western blot, RT-PCR technique, and cell apoptosis/viability/cytotoxicity assays will be used in the analyses. 3. SA3 is to determine whether transplantation of CSC from normal mice will result in greater improvement in cardiac structure and function in infarcted diabetic mouse heart compared with CSC isolated from diabetic mouse heart. The normal mice and diabetic mice will be used to evaluate cardiac function and structural improvements with transplanted CSC. Echocardiography, histological, and pathological techniques will be used in the studies.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR024489-03
Application #
8168211
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
2010-07-01
Project End
2011-06-30
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
3
Fiscal Year
2010
Total Cost
$193,628
Indirect Cost
Name
University of Louisville
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
057588857
City
Louisville
State
KY
Country
United States
Zip Code
40292
Baba, Shahid P; Bhatnagar, Aruni (2018) ROLE OF THIOLS IN OXIDATIVE STRESS. Curr Opin Toxicol 7:133-139
Guo, Yiru; Wysoczynski, Marcin; Nong, Yibing et al. (2017) Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction. Basic Res Cardiol 112:18
Klionsky, Daniel J (see original citation for additional authors) (2016) Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12:1-222
Salabei, Joshua K; Lorkiewicz, Pawel K; Mehra, Parul et al. (2016) Type 2 Diabetes Dysregulates Glucose Metabolism in Cardiac Progenitor Cells. J Biol Chem 291:13634-48
Dassanayaka, Sujith; Jones, Steven P (2015) Recent Developments in Heart Failure. Circ Res 117:e58-63
Brooks, Alan C; DeMartino, Angelica M; Brainard, Robert E et al. (2015) Induction of activating transcription factor 3 limits survival following infarct-induced heart failure in mice. Am J Physiol Heart Circ Physiol 309:H1326-35
Salabei, Joshua K; Lorkiewicz, Pawel K; Holden, Candice R et al. (2015) Glutamine Regulates Cardiac Progenitor Cell Metabolism and Proliferation. Stem Cells 33:2613-27
Salabei, Joshua K; Hill, Bradford G (2015) Autophagic regulation of smooth muscle cell biology. Redox Biol 4:97-103
Muthusamy, Senthilkumar; DeMartino, Angelica M; Watson, Lewis J et al. (2014) MicroRNA-539 is up-regulated in failing heart, and suppresses O-GlcNAcase expression. J Biol Chem 289:29665-76
Salabei, Joshua K; Gibb, Andrew A; Hill, Bradford G (2014) Comprehensive measurement of respiratory activity in permeabilized cells using extracellular flux analysis. Nat Protoc 9:421-38

Showing the most recent 10 out of 98 publications